Care Bare Rx review
Semaglutide and tirzepatide cost the same $199 here. That is unusual.
The verdict
Care Bare Rx charges $199 a month for both molecules. Tirzepatide normally costs more. Here it does not. Injection only, and all fifty states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- States
- 50
- From
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Care Bare Rx sells compounded semaglutide and compounded tirzepatide. Both are weekly injections. Both were advertised at $199 a month. No oral form is listed for either. The service covers all fifty states. Its wider catalog runs to hair, NAD+ and sexual health.
Who writes the prescription, and what do they see?
Treatment is arranged remotely. A prescription is issued before shipping. The pricing page states the rate. It does not describe the prescriber. What the intake asks is not published.
The service is remote and the products are compounded. The catalog is broad rather than weight-loss specific. That is worth knowing. A seller covering six categories is not automatically weaker on one. It does mean the GLP-1 line is not the whole business.
What happens when the dose goes up?
Whether $199 holds as the dose rises is not stated. Most patients escalate within sixteen weeks. That makes it the question to ask. The seller does not answer it.
What the price includes
The flat $199 across both molecules is the whole story. Tirzepatide usually carries a premium over semaglutide. Sellers priced beside it here charge $149 against $199, or $199 against $399. Care Bare Rx charges neither more nor less. A reader who wants tirzepatide pays the semaglutide rate. That is the reason to look at this one.
What it claims, and what it cites
Both products are compounded. A pharmacy prepares them. A manufacturer does not. Neither is FDA-approved. Neither is reviewed for safety, efficacy or quality before dispensing. The trial evidence for these molecules used the approved products at labeled doses. A compounded vial is not measured against that.
Where it holds up, and where it does not
- Strength: Tirzepatide priced at the semaglutide rate
- Strength: All fifty states served
- Strength: One rate to understand, not four
- Limitation: No oral form for either molecule
- Limitation: Dose-escalation pricing not published
- Limitation: GLP-1 is one of six catalog categories
What the evidence says about this kind of treatment
The assessment above is about Care Bare Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants tirzepatide and does not want to pay the premium it usually carries.
- Wrong for
- A reader who wants an oral, since neither molecule is offered in that form here.
The evidence behind what Care Bare Rx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Care Bare Rx compares
| Seller | Who it suits | Go |
|---|---|---|
 CoreAge Rx | A reader still at a starting dose, since that is the tier these rates price. | See CoreAge Rx → |
 Synergy Rx | A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form. | See Synergy Rx → |
 Breeze Meds | A reader comparing a monthly rate against a prepaid block, because this seller publishes both for the same product. | See Breeze Meds → |
More GLP-1 telehealth sellers reviews: ZealthyZera HealthZeussZipHealthZYP Medical10Rx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is tirzepatide really the same price as semaglutide?
- Yes. Both are $199 a month. Most sellers charge more for tirzepatide.
- Can I get an oral here?
- No. Both molecules are sold as weekly injections. No oral line was advertised.
- Does the wide catalog matter?
- Only as context. Care Bare Rx also sells hair, NAD+ and sexual health products. That does not change the GLP-1 rate.
- Is Care Bare Rx expensive compared with other GLP-1 telehealth sellers?
- Care Bare Rx publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Care Bare Rx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.